Disparities Observed in Mortality During COVID-19 Pandemic

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 16, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Oct. 16, 2024 -- During the COVID-19 public health emergency (PHE) period, excess mortality occurred in all racial and ethnic groups, but disparities were observed, according to a study published online Oct. 11 in JAMA Network Open.

Jeremy Samuel Faust, M.D., from Mass General Brigham in Boston, and colleagues characterized overall and age-specific all-cause excess mortality by race and ethnicity during the COVID-19 PHE in a cross-sectional study. Data were included for all U.S. residents and decedents during the COVID-19 PHE period (March 2020 to May 2023).

The researchers found that during the pandemic, there were more than 1.38 million all-cause excess deaths (observed-to-expected ratio, 1.15), corresponding to approximately 23 million years of potential life lost (YPLL). For the total population (all ages), the racial and ethnic groups with the highest observed-to-expected mortality ratios were the American Indian or Alaska Native and Hispanic populations (1.34 and 1.31, respectively). Higher ratios were observed in the U.S. population aged 25 to 64 years (1.20) and were greatest among American Indian or Alaska Native, Hispanic, and Native Hawaiian or Other Pacific Islander groups (1,45, 1.40, and 1.39, respectively). The Black population accounted for 51.1 percent of excess mortality in those younger than 25 years, despite representing 13.8 percent of the population. More than 252,000 (18.3 percent) fewer excess deaths and more than 5.2 million (22.3 percent) fewer YPLL would have occurred if the rate of excess mortality observed among the White population had been observed in the total population.

"The need to address the conditions that create health disparities -- before the next public health crisis -- is evident," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-17 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords